Saturday 17 October 2026 Export MNPR’s income statement to Excel — free account

Monopar Therapeutics Inc.

In the quarter to June 2026, EPS fell 77.1% and free cash flow fell 201.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

69.27 2.53 −3.52%

Follow MNPR

Alert me

Market cap: $481.9M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(26.54%)	(14.22%)	(15.86%)	(19.50%)
ROA Full definition →		(25.88%)	(13.65%)	(15.52%)	(18.90%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(13.74%)	(9.96%)	(11.08%)	(13.65%)
Free Cash Flow per Share Full definition →		(1.52)	(1.65)	(1.17)	(1.43)
Free Cash Flow Full definition →		(10.83)	(12.20)	(10.01)	(12.18)
Other line items
Cash ROIC Full definition →		(3.80%)	(4.39%)	(3.67%)	(4.59%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.56	0.89	0.67	0.68
Depreciation/Fixed assets Full definition →		—	0.00	0.00	0.00
Capex/Depreciation Full definition →		—	0.00	0.00	0.00
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(1.52)	(1.65)	(1.17)	(1.43)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly